Correlation Between Biotechnology Ultrasector and Oakmark Select

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Oakmark Select at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Oakmark Select into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Oakmark Select Fund, you can compare the effects of market volatilities on Biotechnology Ultrasector and Oakmark Select and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Oakmark Select. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Oakmark Select.

Diversification Opportunities for Biotechnology Ultrasector and Oakmark Select

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between Biotechnology and Oakmark is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Oakmark Select Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oakmark Select and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Oakmark Select. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oakmark Select has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Oakmark Select go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Oakmark Select

Assuming the 90 days horizon Biotechnology Ultrasector is expected to generate 5.36 times less return on investment than Oakmark Select. In addition to that, Biotechnology Ultrasector is 2.19 times more volatile than Oakmark Select Fund. It trades about 0.03 of its total potential returns per unit of risk. Oakmark Select Fund is currently generating about 0.32 per unit of volatility. If you would invest  7,803  in Oakmark Select Fund on September 3, 2024 and sell it today you would earn a total of  649.00  from holding Oakmark Select Fund or generate 8.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Biotechnology Ultrasector Prof  vs.  Oakmark Select Fund

 Performance 
       Timeline  
Biotechnology Ultrasector 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Ultrasector Profund are ranked lower than 1 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong forward indicators, Biotechnology Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Oakmark Select 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Oakmark Select Fund are ranked lower than 16 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak essential indicators, Oakmark Select may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Biotechnology Ultrasector and Oakmark Select Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Ultrasector and Oakmark Select

The main advantage of trading using opposite Biotechnology Ultrasector and Oakmark Select positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Oakmark Select can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oakmark Select will offset losses from the drop in Oakmark Select's long position.
The idea behind Biotechnology Ultrasector Profund and Oakmark Select Fund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance